Literature DB >> 6979567

A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.

J W Schrader, I Clark-Lewis.   

Abstract

The production of multipotential hemopoietic stem cells (CFUs) in cultures of murine bone marrow cells is supported by medium conditioned by concanavalin A-stimulated T cell hybridoma 123 or spleen cells. We present physiochemical evidence that this activity of these conditioned media, which we have operationally termed CFUs-stimulating activity (CFUs-SA), is due to a new T cell-derived lymphokine. CFUs-SA was shown by gel filtration to reside in a distinct fraction corresponding to a mean apparent m.w. of 29,000, and was distinguishable from T cell growth factor, not only by its lower apparent m.w. but also by chromatography using Phenyl-Sepharose. After isoelectric focusing of neuraminidase-treated conditioned medium, CFUs-SA was found between isoelectric points 5 and 8. In this respect, CFUs-SA appeared similar to another factor, P cell-stimulating factor, which stimulates the growth of persisting (P) cells (homogeneous populations of cells resembling mast cells) and that occurred together with CFUs-SA in both the spleen and hybridoma-conditioned media. Isoelectric focusing separated CFUs-SA from granulocyte-macrophage colony-stimulating factor, which focused as a single peak with an isoelectric point around 5.0. Thus CFUs-SA is due to a T cell-derived factor that is separable from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor, but has similar properties to P cell-stimulating factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979567

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Murine splenic null cell compartment contains distinct haemopoietic subpopulations: enlargement of a myeloid and an undifferentiated subset with the development of splenomegaly in New Zealand black mice.

Authors:  V Manohar; E M Brown; T M Chused
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Evidence for the in vivo production and release into the serum of a T-cell lymphokine, persisting-cell stimulating factor (PSF), during graft-versus-host reactions.

Authors:  R M Crapper; J W Schrader
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

3.  Hemopoiesis and differentiation.

Authors:  M L Patchen
Journal:  Surv Immunol Res       Date:  1984

4.  Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells.

Authors:  M Ogawa; T Nakahata; A G Leary; A R Sterk; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  The in vivo functions and properties of persisting cell-stimulating factor.

Authors:  R M Crapper; I Clark-Lewis; J W Schrader
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

6.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

7.  Interleukin 3 promotes erythroid burst formation in "serum-free" cultures without detectable erythropoietin.

Authors:  J W Goodman; E A Hall; K L Miller; S G Shinpock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Viral infection of vascular endothelial cells alters production of colony-stimulating activity.

Authors:  S L Gerson; H M Friedman; D B Cines
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

Authors:  J L Spivak; R R Smith; J N Ihle
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 10.  Toward a Molecular Understanding of Adaptive Immunity: A Chronology, Part III.

Authors:  Kendall A Smith
Journal:  Front Immunol       Date:  2014-02-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.